Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma (Q70902037)
Jump to navigation
Jump to search
scientific article published on 01 January 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma |
scientific article published on 01 January 1996 |
Statements
Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma (English)
P Sonneveld
P W Wijermans
M van Marwijk Kooy
O J Meuwissen
R H van Oers
R van der Griend